Evidence-Based Complementary and Alternative Medicine

Bioactives and Traditional Herbal Medicine for the Treatment of Cardiovascular/Cerebrovascular Diseases


Publishing date
28 Mar 2014
Status
Published
Submission deadline
08 Nov 2013

Lead Editor

1Department of Pharmacology, Graduate Institute of Medical Sciences, Office of Research & Development, Taipei Medical University, Taipei, Taiwan

2Department of Animal Science, School of Life Sciences, Bharathidasan University, Tiruchirappalli, Tamil Nadu 620 024, India

3Department of Pharmacology, National Defense Medical Center, Taipei, Taiwan


Bioactives and Traditional Herbal Medicine for the Treatment of Cardiovascular/Cerebrovascular Diseases

Description

Cardiovascular and cerebrovascular diseases are the leading causes of deaths worldwide. Based on the current epidemiological data, it is estimated that, till 2020, coronary artery disease and cerebral hemorrhage are still the first and second causes of death of human being, even though the order of the death causes due to human diseases will be changed significantly. Despite various advances in the understanding of the diseases, pharmacological treatment by conventional medicine has not obtained satisfactory results. However, recent studies suggest that natural products and traditional herbal medicine are a potential candidate for the preventative treatment of the disorders.

Therefore, we invite investigators to contribute original research articles as well as review articles that provide solid evidence to support the application of bioactives/traditional herbal medicine (THM) in prevention and treatment of cardiovascular and cerebrovascular diseases. We are particularly interested in articles reporting randomized, double-blind, and placebo-controlled trials or revealing the action mechanisms of bioactives/THM by using cellular or animal models. Potential topics include, but are not limited to:

  • Experimental and clinical trials of THM on prophylactic and/or therapeutic treatments of cardiovascular and cerebrovascular diseases
  • Recent applications of bioactives and THM in treatment of cerebral and coronary thrombosis by using animal models
  • Advances in revealing acting targets of bioactives and THM in treating cardiovascular and cerebrovascular diseases
  • Advances in identifying active ingredients of nutritional and medicinal herbs against cardiovascular and cerebrovascular diseases
  • Current and probable strategies of phytoconstituents and THM for combating cardiovascular and cerebrovascular diseases
  • Current status of experimental and clinical trials and systematic reviews, including research trend, achievements, and problems are also welcome
  • Ethnopharmacological studies of bioactives and THM used in the treatment of cerebrovascular diseases

Before submission authors should carefully read over the journal’s Author Guidelines, which are located at http://www.hindawi.com/journals/ecam/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/submit/journals/ecam/cvc/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2014
  • - Article ID 495323
  • - Editorial

Bioactives and Traditional Herbal Medicine for the Treatment of Cardiovascular/Cerebrovascular Diseases

Joen-Rong Sheu | Pitchairaj Geraldine | Mao-Hsiung Yen
  • Special Issue
  • - Volume 2014
  • - Article ID 634695
  • - Research Article

Modulation of Cardiac Autonomic Dysfunction in Ischemic Stroke following Ayurveda (Indian System of Medicine) Treatment

Sriranjini Sitaram Jaideep | Dindagur Nagaraja | ... | Sathyaprabha N. Talakad
  • Special Issue
  • - Volume 2014
  • - Article ID 465640
  • - Research Article

Guanxinkang Decoction Exerts Its Antiatherosclerotic Effect Partly through Inhibiting the Endoplasmic Reticulum Stress

Hao Wang | Zhi-Min Zheng | Bu-Lang Gao
  • Special Issue
  • - Volume 2014
  • - Article ID 696218
  • - Research Article

Qingkailing Suppresses the Activation of BV2 Microglial Cells by Inhibiting Hypoxia/Reoxygenation-Induced Inflammatory Responses

Lulu Mana | Shan Wang | ... | Yonghong Gao
  • Special Issue
  • - Volume 2014
  • - Article ID 571076
  • - Research Article

Time-Course of the Effects of QSYQ in Promoting Heart Function in Ameroid Constrictor-Induced Myocardial Ischemia Pigs

Qi Qiu | Yang Lin | ... | Wei Wang
  • Special Issue
  • - Volume 2014
  • - Article ID 157938
  • - Research Article

Neuroprotective Effect of a Formula, Moschus Combined with Borneolum Synthcticum, from Traditional Chinese Medicine on Ischemia Stroke in Rats

Xin-hua Xia | Qiang Li | Mei Liu
  • Special Issue
  • - Volume 2014
  • - Article ID 309378
  • - Research Article

Anti-Inflammatory Effects of the Chinese Herbal Formula Sini Tang in Myocardial Infarction Rats

Jiangang Liu | Karoline Peter | ... | Yan Ma
  • Special Issue
  • - Volume 2014
  • - Article ID 890950
  • - Review Article

Chinese Herbal Medicine for Aspirin Resistance: A Systematic Review of Randomized Controlled Trials

Ai-ju Liu | Hui-qin Li | ... | Guo-qing Zheng
  • Special Issue
  • - Volume 2014
  • - Article ID 639548
  • - Research Article

Antiplatelet Activity of Morus alba Leaves Extract, Mediated via Inhibiting Granule Secretion and Blocking the Phosphorylation of Extracellular-Signal-Regulated Kinase and Akt

Dong-Seon Kim | Hyun Dong Ji | ... | Ho-Kyoung Kim
  • Special Issue
  • - Volume 2014
  • - Article ID 478973
  • - Research Article

Antihypercholesterolemic and Antioxidative Potential of an Extract of the Plant, Piper betle, and Its Active Constituent, Eugenol, in Triton WR-1339-Induced Hypercholesterolemia in Experimental Rats

Karuppasamy Venkadeswaran | Arumugam Ramachandran Muralidharan | ... | Pitchairaj Geraldine
Evidence-Based Complementary and Alternative Medicine
 Journal metrics
Acceptance rate27%
Submission to final decision68 days
Acceptance to publication33 days
CiteScore2.900
Impact Factor1.813
 Submit

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.